Comparison · hormone optimization

TRT vs BHRT

TRT and BHRT are both provider-reviewed hormone optimization pathways anchored to the same standardized biomarker panel. TRT addresses male testosterone deficiency. BHRT addresses female estrogen, progesterone, and (where indicated) testosterone imbalance through perimenopause, menopause, or select premenopausal contexts. Candidacy, modality, and cadence differ — the operating principles are shared.

Reviewed by Dr. Laura PurdyMay 29, 2026

Attribute

TRT (Testosterone optimization)

BHRT (Bioidentical hormone optimization)

Primary candidates

Adult men with confirmed low testosterone and supporting symptom profile

Women in perimenopause, menopause, surgical menopause, or select premenopausal hormonal imbalance

Hormones optimized

Testosterone (with estradiol and SHBG read in context)

Estradiol, progesterone, and — where indicated — testosterone

Biomarker panel

Hormones, Lipids, CBC, CMP — required at baseline and recalibration cadence

Both pathways share the same standardized panel.

Hormones, Lipids, CBC, CMP — required at baseline and recalibration cadence

Delivery modalities

Injectable, oral, topical, nasal

Modality is provider-reviewed against biomarkers, lifestyle, and continuity preference.

Transdermal, oral, injectable, topical

Recalibration cadence

First read typically 8–12 weeks, then ongoing provider-defined cadence

First read typically 8–12 weeks, then ongoing cadence tuned to phase and trajectory

Onset of subjective signals

Energy, mood, libido often within 2–4 weeks

Symptom relief (vasomotor, sleep, mood) typically within weeks to months

Continuity model

Synchronous video review + Vitality membership

Choose TRT (Testosterone optimization)

TRT is the provider-reviewed pathway when biomarkers and symptoms confirm male testosterone deficiency and the patient is a candidate after cardiovascular, fertility, and hematologic review.

Explore pathway

Choose BHRT (Bioidentical hormone optimization)

BHRT is the provider-reviewed pathway when symptoms and biomarkers reflect female hormonal transition or imbalance — perimenopause, menopause, surgical menopause, or select premenopausal contexts.

Explore pathway

Educational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.

Frequently asked

Can TRT and BHRT use the same delivery modality?

Several modalities overlap (injectable, topical, oral), but dose, formulation, and cadence are entirely different and always provider-reviewed.

Is the biomarker panel different for TRT and BHRT?

The four-panel structure (Hormones, Lipids, CBC, CMP) is the same; the specific hormones interpreted within the panel differ.

Next step

Take the optimization assessment.

The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.

Begin assessment